Cholesterol
- Generic Name
- Cholesterol
- Drug Type
- Small Molecule
- Chemical Formula
- C27H46O
- CAS Number
- 57-88-5
- Unique Ingredient Identifier
- 97C5T2UQ7J
- Background
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Not Applicable
Not yet recruiting
- Conditions
- Acute Coronary SyndromeNon ST Segment Elevation Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- China National Center for Cardiovascular Diseases
- Target Recruit Count
- 3684
- Registration Number
- NCT06096909
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Early Phase 1
Active, not recruiting
- Conditions
- Pancreas CancerPancreatic Ductal AdenocarcinomaPancreatic CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- CHU de Quebec-Universite Laval
- Target Recruit Count
- 3
- Registration Number
- NCT04862260
- Locations
- 🇨🇦
CHUM, Montreal, Quebec, Canada
🇨🇦CHU de Québec-Université Laval, Quebec city, Quebec, Canada
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Phase 2
Recruiting
- Conditions
- Smith-Lemli-Opitz SyndromeHearing LossCone-Rod Dystrophy
- Interventions
- Drug: Antioxidants
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 100
- Registration Number
- NCT01773278
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
Study of Smith-Lemli-Opitz Syndrome
Completed
- Conditions
- Smith-Lemli-Opitz Syndrome
- Interventions
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Target Recruit Count
- 130
- Registration Number
- NCT00001721
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath